These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 28085233

  • 1. Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples.
    Reynolds JP, Zhou Y, Jakubowski MA, Wang Z, Brainard JA, Klein RD, Farver CF, Almeida FA, Cheng YW.
    Cancer Cytopathol; 2017 Mar; 125(3):178-187. PubMed ID: 28085233
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing.
    Xu X, Yang Y, Li H, Chen Z, Jiang G, Fei K.
    Scand J Clin Lab Invest; 2016 Sep; 76(5):386-92. PubMed ID: 27215271
    [Abstract] [Full Text] [Related]

  • 3. Construction of a reference material panel for detecting KRAS/NRAS/EGFR/BRAF/MET mutations in plasma ctDNA.
    Xu J, Qu S, Sun N, Zhang W, Zhang J, Song Q, Lin M, Gao W, Zheng Q, Han M, Na C, Xu R, Chang X, Yang X, Huang J.
    J Clin Pathol; 2021 May; 74(5):314-320. PubMed ID: 32817175
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Next-Generation Sequencing, Quantitative PCR, and Sanger Sequencing for Mutation Profiling of EGFR, KRAS, PIK3CA and BRAF in Clinical Lung Tumors.
    Gao J, Wu H, Shi X, Huo Z, Zhang J, Liang Z.
    Clin Lab; 2016 May; 62(4):689-96. PubMed ID: 27215089
    [Abstract] [Full Text] [Related]

  • 5. Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
    Malapelle U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Savic S, Bihl M, Bubendorf L, Salto-Tellez M, de Biase D, Tallini G, Hwang DH, Sholl LM, Luthra R, Weynand B, Vander Borght S, Missiaglia E, Bongiovanni M, Stieber D, Vielh P, Schmitt F, Rappa A, Barberis M, Pepe F, Pisapia P, Serra N, Vigliar E, Bellevicine C, Fassan M, Rugge M, de Andrea CE, Lozano MD, Basolo F, Fontanini G, Nikiforov YE, Kamel-Reid S, da Cunha Santos G, Nikiforova MN, Roy-Chowdhuri S, Troncone G, Molecular Cytopathology Meeting Group.
    Cancer Cytopathol; 2017 Aug; 125(8):615-626. PubMed ID: 28475299
    [Abstract] [Full Text] [Related]

  • 6. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY, Kim SH, Lee YS, Lee SY, Hwang JA, Kim JY, Yoon SJ, Lee GK.
    Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
    [Abstract] [Full Text] [Related]

  • 7. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
    Jing C, Mao X, Wang Z, Sun K, Ma R, Wu J, Cao H.
    Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
    [Abstract] [Full Text] [Related]

  • 8. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, Pfeifer JD, Morgensztern D, Govindan R.
    Cancer; 2015 Feb 15; 121(4):631-9. PubMed ID: 25345567
    [Abstract] [Full Text] [Related]

  • 9. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
    Xie F, Zheng X, Mao X, Zhao R, Ye J, Zhang Y, Sun J.
    Ann Thorac Surg; 2019 Jul 15; 108(1):219-226. PubMed ID: 30885850
    [Abstract] [Full Text] [Related]

  • 10. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
    Allison DB, Lilo MT, Geddes S, Pallavajjalla A, Askin F, Gabrielson E, Zheng G, Li QK.
    Cancer Cytopathol; 2016 Jul 15; 124(7):485-92. PubMed ID: 27007084
    [Abstract] [Full Text] [Related]

  • 11. High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules.
    Wu C, Zhao C, Yang Y, He Y, Hou L, Li X, Gao G, Shi J, Ren S, Chu H, Zhou C, Zhang J, Schmid-Bindert G.
    J Thorac Oncol; 2015 May 15; 10(5):778-783. PubMed ID: 25629635
    [Abstract] [Full Text] [Related]

  • 12. Sensitive genotyping of somatic mutations in the EGFR, KRAS, PIK3CA, BRAF genes from NSCLC patients using hydrogel biochips.
    Emelyanova M, Arkhipova K, Mazurenko N, Chudinov A, Demidova I, Zborovskaya I, Lyubchenko L, Zasedatelev A, Nasedkina T.
    Appl Immunohistochem Mol Morphol; 2015 Apr 15; 23(4):255-65. PubMed ID: 25153497
    [Abstract] [Full Text] [Related]

  • 13. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.
    van Eijk R, Licht J, Schrumpf M, Talebian Yazdi M, Ruano D, Forte GI, Nederlof PM, Veselic M, Rabe KF, Annema JT, Smit V, Morreau H, van Wezel T.
    PLoS One; 2011 Mar 08; 6(3):e17791. PubMed ID: 21408138
    [Abstract] [Full Text] [Related]

  • 14. Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients.
    Martín Martorell P, Huerta M, Compañ Quilis A, Abellán R, Seda E, Blesa S, Chaves FJ, Dualde Beltrán D, Roselló Keränen S, Franco J, Insa A.
    Clin Lung Cancer; 2017 Nov 08; 18(6):e395-e402. PubMed ID: 28550959
    [Abstract] [Full Text] [Related]

  • 15. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
    Reynolds JP, Tubbs RR, Minca EC, MacNamara S, Almeida FA, Ma PC, Pennell NA, Cicenia JC.
    Lung Cancer; 2014 Nov 08; 86(2):158-63. PubMed ID: 25263855
    [Abstract] [Full Text] [Related]

  • 16. Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.
    Oezkan F, Herold T, Darwiche K, Eberhardt WEE, Worm K, Christoph DC, Wiesweg M, Freitag L, Schmid KW, Theegarten D, Hager T, Koenig MJ, He K, Taube C, Schuler M, Breitenbuecher F.
    Clin Lung Cancer; 2018 Nov 08; 19(6):e879-e884. PubMed ID: 30206042
    [Abstract] [Full Text] [Related]

  • 17. Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.
    Sholl LM, Aisner DL, Varella-Garcia M, Berry LD, Dias-Santagata D, Wistuba II, Chen H, Fujimoto J, Kugler K, Franklin WA, Iafrate AJ, Ladanyi M, Kris MG, Johnson BE, Bunn PA, Minna JD, Kwiatkowski DJ, LCMC Investigators.
    J Thorac Oncol; 2015 May 08; 10(5):768-777. PubMed ID: 25738220
    [Abstract] [Full Text] [Related]

  • 18. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL, Montgomery ND, Patel NM, Civalier CJ, Dodd LG, Gulley ML, Booker JK, Weck KE.
    Cancer Cytopathol; 2016 Jun 08; 124(6):406-14. PubMed ID: 26882436
    [Abstract] [Full Text] [Related]

  • 19. Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.
    Bozzetti C, Naldi N, Nizzoli R, Azzoni C, Bortesi B, Zobbi V, Bottarelli L, Tiseo M, Gasparro D, Majori M, De Filippo M, Ardizzoni A.
    Lung Cancer; 2013 Apr 08; 80(1):35-8. PubMed ID: 23352033
    [Abstract] [Full Text] [Related]

  • 20. Genomic profiling in a homogeneous molecular subtype of non-small cell lung cancer: An effort to explore new drug targets.
    Veldore VH, Patil S, Satheesh CT, Shashidhara HP, Tejaswi R, Prabhudesai SA, Krishnamoorthy N, Hazarika D, Naik R, Rao RM, Ajai Kumar BS.
    Indian J Cancer; 2015 Apr 08; 52(2):243-8. PubMed ID: 26853422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.